802 research outputs found

    sj-docx-3-tct-10.1177_15330338211043976 - Supplemental material for MiR-18a-5p Facilitates Progression of Hepatocellular Carcinoma by Targeting CPEB3

    No full text
    Supplemental material, sj-docx-3-tct-10.1177_15330338211043976 for MiR-18a-5p Facilitates Progression of Hepatocellular Carcinoma by Targeting CPEB3 by Mingxin Cui, Fengzhi Qu, Libing Wang, Daming Cheng and Xiaogang Liu in Technology in Cancer Research & Treatment</p

    sj-docx-2-tct-10.1177_15330338211043976 - Supplemental material for MiR-18a-5p Facilitates Progression of Hepatocellular Carcinoma by Targeting CPEB3

    No full text
    Supplemental material, sj-docx-2-tct-10.1177_15330338211043976 for MiR-18a-5p Facilitates Progression of Hepatocellular Carcinoma by Targeting CPEB3 by Mingxin Cui, Fengzhi Qu, Libing Wang, Daming Cheng and Xiaogang Liu in Technology in Cancer Research & Treatment</p

    sj-pdf-1-tct-10.1177_15330338211043976 - Supplemental material for MiR-18a-5p Facilitates Progression of Hepatocellular Carcinoma by Targeting CPEB3

    No full text
    Supplemental material, sj-pdf-1-tct-10.1177_15330338211043976 for MiR-18a-5p Facilitates Progression of Hepatocellular Carcinoma by Targeting CPEB3 by Mingxin Cui, Fengzhi Qu, Libing Wang, Daming Cheng and Xiaogang Liu in Technology in Cancer Research & Treatment</p

    sj-xlsx-5-tct-10.1177_15330338211043976 - Supplemental material for MiR-18a-5p Facilitates Progression of Hepatocellular Carcinoma by Targeting CPEB3

    No full text
    Supplemental material, sj-xlsx-5-tct-10.1177_15330338211043976 for MiR-18a-5p Facilitates Progression of Hepatocellular Carcinoma by Targeting CPEB3 by Mingxin Cui, Fengzhi Qu, Libing Wang, Daming Cheng and Xiaogang Liu in Technology in Cancer Research & Treatment</p

    sj-docx-4-tct-10.1177_15330338211043976 - Supplemental material for MiR-18a-5p Facilitates Progression of Hepatocellular Carcinoma by Targeting CPEB3

    No full text
    Supplemental material, sj-docx-4-tct-10.1177_15330338211043976 for MiR-18a-5p Facilitates Progression of Hepatocellular Carcinoma by Targeting CPEB3 by Mingxin Cui, Fengzhi Qu, Libing Wang, Daming Cheng and Xiaogang Liu in Technology in Cancer Research & Treatment</p

    New reactions and strategies in divergent syntheses of macrolide antibiotics

    No full text
    From the microbial world, antibiotics are structurally complex and highly potent chemical weapons that co-evolved with bacteria. Macrolide (glycosylated cyclic polyketides) antibiotics have been used extensively as first-line antibacterial agents since the discovery of the broad-spectrum antibiotic erythromycin A in 1952. However wide-spread use of antibiotics has led pathogens to develop drug resistance. Therefore new and enhanced antibiotics are constantly in need. Described in this dissertation is my effort to emulate the synthetic capabilities of erythromycin-producing bacteria by accessing novel erythromycin-inspired polyketides via divergent total synthesis. New allene oxidation methods have been developed and implemented in a modular and divergent route to produce a diversified portfolio of cyclic polyketides and their glycoconjugates. I will disclose a total synthesis of 4,10-didesmethyl-(9S)-dihydroerythronolide A (Chapter 2), preparation of glycosylated erythromycin analogs (Chapter 3) and progress towards synthesis of 9(S)-dihydroerythronolide A (Chapter 4).Ph.D.Includes bibliographical referencesby Libing Y

    Who is the Exchange Rate Manipulator: China or America?

    No full text
    The manipulation of the US dollar and other countries' currencies has been a longstanding American prerogative, thus American politicians and scholars are accustomed to labeling countries that fight against American policies on the US dollar as “currency manipulators.” The substance of America's accusation of currency manipulation against China is that when America starts to control dollars in order to transfer its domestic economic problems abroad, China is expected to do nothing and simply live with an unstable RMB exchange rate. Obviously, there is a great difference between China and Japan. China will never allow itself to become “the second Japan” that swallows bitter pills like the Plaza Accord
    corecore